ATC

ATC-Index C10BB02

You are here: Startseite > ATC > C > C10 > C10B > C10BB

- ATC
Anatomisch-therapeutisch-chemische-Klassifikation mit Tagesdosen (ATC)
- C
KARDIOVASKULÄRES SYSTEM
- C10
MITTEL, DIE DEN LIPIDSTOFFWECHSEL BEEINFLUSSEN
- C10B
MITTEL, DIE DEN LIPIDSTOFFWECHSEL BEEINFLUSSEN, KOMBINATIONEN
- C10BB
Fibrate in Kombination mit anderen Mitteln, die den Lipidstoffwechsel beeinflussen

C10BB02

Clofibrat in Kombination mit anderen Mitteln, die den Lipidstoffwechsel beeinflussen

ATC Code C10BB02 für Clofibrat in Kombination mit anderen Mitteln, die den Lipidstoffwechsel beeinflussen

ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us